Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115635
Status:
COMPLETED
Last Update Posted:
2007-10-02
First Post:
2005-06-23
Brief Title:
Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer
Sponsor:
Herlev Hospital
Organization:
Herlev Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostate Cancer |
Keywords:
| Name | View |
|---|---|
| Hormonal refractory chemotherapy docetaxel gemcitabine | View |